Updated follow‐up of BELLWAVE‐001: an open‐label, single‐arm, phase 1/2 study of the efficacy and safety of nemtabrutinib for the treatment of B‐cell malignancies

Updated follow‐up of BELLWAVE‐001: an open‐label, single‐arm, phase 1/2 study of the efficacy and safety of nemtabrutinib for the treatment of B‐cell malignancies

Saved in:
Bibliographic Details
Published in:Hematological oncology Vol. 41; no. S2; pp. 565 - 567
Main Authors: Eradat, H., Woyach, J., Flinn, I. W., Awan, F. T., Brander, D., Tees, M., Parikh, S. A., Phillips, T., Ghori, R., Paydar, I., Farooqui, M. Z. H., Byrd, J. C., Stephens, D. M.
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-06-2023
Subjects:
Malignancy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3164_423